Specialties
Education
- MPhil, University of Cambridge, Cambridge, UK
- MD, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
- General Surgery Residency, Hospital of the University of Pennsylvania, Philadelphia, PA
- Cardiothoracic Surgery Fellowship, Stanford University, Stanford, CA
Clinical Specialties
Dr. Kennedy is an adult thoracic surgeon whose practice centers on lung, esophageal, and mediastinal tumors, benign foregut conditions, and chest wall disorders.
Research Interests
Dr. Kennedy leads basic and translational research efforts within the Thoracic Section of the Division of Cardiothoracic Surgery. The primary focus of his laboratory is developing intraoperative molecular imaging technology to improve outcomes for cancer surgery. He has published extensively on this topic, and received research funding from the NIH, the American Philosophical Society, and the American Association for Thoracic Surgery.
Recent Publications
Fibroblast activation protein-targeted near-infrared labeling of cancer-associated fibroblasts in a non-small-cell lung cancer tumor microenvironment.
Azari F, Kennedy GT, Folkert I, Jones G, Chang A, Nadeem B, Chang AB, Conner A, Sullivan NT, Singhal S
Sci Rep 2026 Jul 12;
[PubMed ID: 42437801]Machine Learning-Guided Detection of Malignancy of Lung Nodules With Molecular Imaging-Guided Surgery.
Azari F, Kennedy GT, Hanna A, Chang A, Chang A, Nadeem B, Din A, Delikatny E, Kucharczuk J, Azari S, Singhal S
JAMA Netw Open 2026 Jan 02; 9(1): e2551734
[PubMed ID: 41528749]Surgical impact of pafolacianine-based intraoperative molecular imaging in lobar versus sublobar pulmonary resection.
Kennedy GT, Azari FS, Singhal S, Chen L, Gruev V, Delikatny E, Singhal S
JTCVS Tech 2025 Dec; 34: 219-221
[PubMed ID: 41368366]A fibroblast activation protein targeted optical tracer for identifying primary and metastatic sarcoma during resection.
Azari F, Kennedy GT, Folkert I, Jones G, Chang A, Conner A, Bernstein E, Nadeem B, Sullivan NT, Eruslanov E, Albelda S, Low P, Singhal S
EJNMMI Res 2025 Jul 29; 15(1): 94
[PubMed ID: 40728760]A Phase 2 Multicenter Clinical Trial of Intraoperative Molecular Imaging of Lung Cancer with a pH-Activatable Nanoprobe.
Kennedy GT, Azari FS, Chang A, Bou-Samra P, Desphande C, Predina J, Delikatny EJ, Olson M, Rice DC, Singhal S
Mol Imaging Biol 2024 Aug; 26(4): 585-592
[PubMed ID: 38992245]